NCRI Press Release, 8 November 2010
Test selects 60 per cent of women with inherited ovarian cancer who could benefit from ‘smart’ drug
Download the attachment
Recent Tweets
-
RT @breastcancernow : 🧪 We want to get researchers talking about science, in a simplified way. This competition is open to current graduate…
10 hours ago -
Attending #NCRI2018? @breastcancernow are challenging you to describe your research project in a simplified and und… https://t.co/FWJg3Vq6Ai
1 day ago -
Final call for registrations! Secure your place at #NCRI2018 before midnight: https://t.co/BXFCISwGHF
2 days ago
What's Happening
- 9 Oct 2018NCRI’s Chairs’ Forum round-up: latest on our work to accelerate cancer research
- 13 Aug 2018Register now for the 5th Annual Children's Cancer & Leukaemia Trials Meeting: 26 November 2018
- 25 Jul 2018Redesigning clinical research to improve outcomes for older people
- 18 May 2018NCRI Consumer Membership Applications to the CSGs - Closing Soon!
- 3 May 2018Dr Iain Frame appointed NCRI CEO
RSS Feed